EPR21-037: Prevalence of Low HER2 Expression Among HER2 Negative Metastatic Breast Cancer Patients in U.S: Multi-Site, Retrospective Chart Review Study

Authors:
Sandhya Mehta Daiichi Sankyo, Inc., Basking Ridge, NJ

Search for other papers by Sandhya Mehta in
Current site
Google Scholar
PubMed Close
 MS, PhD
,
Winghan Kwong Daiichi Sankyo, Inc., Basking Ridge, NJ

Search for other papers by Winghan Kwong in
Current site
Google Scholar
PubMed Close
 PhD
,
Angelica Falkenstein Cardinal Health, Dublin, OH

Search for other papers by Angelica Falkenstein in
Current site
Google Scholar
PubMed Close
 PhD, MA
,
Melissa Pavilack AstraZeneca, Gaithersburg, MD

Search for other papers by Melissa Pavilack in
Current site
Google Scholar
PubMed Close
 PharmD
, and
Jonathan Kish Cardinal Health, Dublin, OH

Search for other papers by Jonathan Kish in
Current site
Google Scholar
PubMed Close
 PhD, MPH
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7741
Restricted access

Corresponding Author: Sandhya Mehta, MS, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1469 438 62
PDF Downloads 705 0 0
EPUB Downloads 0 0 0